A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms
Open Access
- 1 January 2017
- journal article
- research article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 75, 83-90
Abstract
No abstract availableKeywords
Funding Information
- “Conselho Nacional de Desenvolvimento Científico e Tecnológico” CNPq-Brazil Program Ciência sem Fronteiras CNPJ (401898/2013-0)
- RCUK/FAPESP Newton grant (MR/M026574/1, 2014/50829-4)
This publication has 52 references indexed in Scilit:
- Early Life Emotional, Physical, and Sexual Abuse and the Development of Premenstrual Syndrome: A Longitudinal StudyJournal of Women's Health, 2014
- Allopregnanolone and mood disordersProgress in Neurobiology, 2014
- SRD5A1 Genotype Frequency Differences in Women with Mild versus Severe Premenstrual SymptomsIssues in Mental Health Nursing, 2012
- Adiposity and the Development of Premenstrual SyndromeJournal of Women's Health, 2010
- Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulatorsPsychoneuroendocrinology, 2009
- Allopregnanolone concentration and mood—a bimodal association in postmenopausal women treated with oral progesteronePsychopharmacology, 2006
- Anxiolytic Effect of Progesterone is Mediated by the Neurosteroid Allopregnanolone at Brain GABAA ReceptorsJournal of Neuroendocrinology, 1995
- Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptorBrain Research, 1991
- Mood, Sexuality, Hormones, and the Menstrual Cycle. II. Hormone Levels and Their Relationship to the Premenstrual SyndromePsychosomatic Medicine, 1983
- Plasma Concentration of LH, FSH, Prolactin, Progesterone and Estradiol-17β Throughout the 4-Day Estrous Cycle of the RatEndocrinology, 1974